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1	Introduction
Identifying	 predictive	 biomarkers	 of	 human	 appearance	 traits	 is	 being	 systematically	 investigated	 by	 the	 forensic	 community	 with	 the	 purpose	 of	 individual	 identification	 merely	 from	 a	 biological	 sample	 [1].	 Human
pigmentation	traits	are	some	of	the	most	differentiable	externally	visible	characteristics	among	individuals.	For	this	reason,	researchers	have	been	focused	in	the	design	of	genetic	prediction	tests	for	eye,	skin	and	hair	colour	variation
[2–7].	However,	DNA-based	prediction	of	other	human	pigmentation	traits	under	a	strong	genetic	control,	such	as	ephelides	occurrence,	has	not	been	generated	yet.
Ephelides	(also	known	as	freckles)	are	small,	flat,	pale-brown	spots	commonly	observed	in	fair-skinned	and/or	red-haired	individuals.	Ephelides	typically	appear	early	in	childhood,	may	increase	in	size,	number	and	intensity
during	adolescence	and	partly	disappear	during	the	young	adulthood	period	[8].	Although	the	development	of	these	hyperpigmented	spots	may	be	triggered	by	exposure	to	sunlight,	the	occurrence	of	ephelides	is	largely	genetically
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Abstract
Prediction	of	human	pigmentation	traits,	one	of	the	most	differentiable	externally	visible	characteristics	among	individuals,	from	biological	samples	represents	a	useful	tool	in	the	field	of	forensic	DNA	phenotyping.	In
spite	of	freckling	being	a	relatively	common	pigmentation	characteristic	in	Europeans,	little	is	known	about	the	genetic	basis	of	this	largely	genetically	determined	phenotype	in	southern	European	populations.	In	this	work,
we	explored	the	predictive	capacity	of	eight	freckle	and	sunlight	sensitivity-related	genes	in	458	individuals	(266	non-freckled	controls	and	192	freckled	cases)	from	Spain.	Four	loci	were	associated	with	freckling	(MC1R,
IRF4,	ASIP	and	BNC2),	and	female	sex	was	also	found	to	be	a	predictive	factor	for	having	a	freckling	phenotype	in	our	population.	After	identifying	the	most	informative	genetic	variants	responsible	for	human	ephelides
occurrence	in	our	sample	set,	we	developed	a	DNA-based	freckle	prediction	model	using	a	multivariate	regression	approach.	Once	developed,	the	capabilities	of	the	prediction	model	were	tested	by	a	repeated	10-fold	cross-
validation	approach.	The	proportion	of	correctly	predicted	individuals	using	the	DNA-based	freckle	prediction	model	was	74.13%.	The	implementation	of	sex	into	the	DNA-based	freckle	prediction	model	slightly	improved	the
overall	prediction	accuracy	by	2.19%	 (76.32%).	Further	evaluation	of	 the	newly-generated	prediction	model	was	performed	by	assessing	 the	model’s	performance	 in	a	new	cohort	of	212	Spanish	 individuals,	 reaching	a
classification	success	rate	of	74.61%.	Validation	of	this	prediction	model	may	be	carried	out	in	larger	populations,	including	samples	from	different	European	populations.	Further	research	to	validate	and	improve	this	newly-
generated	freckle	prediction	model	will	be	needed	before	its	forensic	application.	Together	with	DNA	tests	already	validated	for	eye	and	hair	colour	prediction,	this	freckle	prediction	model	may	lead	to	a	substantially	more
detailed	physical	description	of	unknown	individuals	from	DNA	found	at	the	crime	scene.
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determined	[9].	The	melanocortin-1	receptor	(MC1R)	gene	seems	to	be	the	major	contributor	to	the	formation	of	freckles	in	European-origin	individuals,	independent	of	skin	type	and	hair	colour	[10,11].	From	all	non-synonymous	allelic
variants	found	in	the	MC1R	gene,	six	have	been	traditionally	associated	with	a	more	severe	phenotype,	characterised	by	fair	skin,	red	hair	and	freckling	(known	as	the	RHC	phenotype):	D84E,	R142H,	R151C,	I155T,	R160W	and	D294H
[11,12].	Functional	analyses	have	demonstrated	that	these	MC1R	genetic	variants	severely	affect	receptor	function	reducing	stimulation	of	the	pigmentation	pathway.	These	six	variants	as	well	as	other	rare	alleles	that	completely
hamper	MC1R	function	are	known	as	‘R’	alleles.	Alternatively,	weaker	variants	with	lower	penetrance	are	classified	as	‘r’	alleles,	and	other	rare	non-synonymous	variants	that	do	not	seem	to	have	a	noticeable	effect	in	receptor	function
are	defined	as	pseudoalleles	[13].
The	presence	of	 alleles	with	 impaired	 function	ultimately	 results	 in	 an	 increased	 synthesis	 of	 phaeomelanin	 (instead	of	 eumelanin)	 in	melanocytes	 [13–15].	Nevertheless,	 it	 is	 thought	 that	 other	genes	must	 contribute	 to
freckling,	since	a	significant	percentage	of	the	individuals	with	freckles	do	not	harbour	mutations	in	the	MC1R	gene.	Accordingly,	other	genes	have	also	been	associated	with	ephelides	occurrence	via	genome-wide	association	studies,
including	IRF4,	ASIP,	TYR	and	BNC2	[16–18].
In	this	work,	we	analysed	the	role	of	eight	genes	previously	associated	with	sunlight	sensitivity	in	an	ephelides	case-control	study.	As	far	as	we	know,	this	study	tackles	for	the	first	time	the	genetic	basis	of	freckles	in	a	southern
European	population	(Spain),	where	the	freckling	genotype	presents	a	reduced	frequency	compared	to	northern	Europe.	After	performing	an	association	study,	we	developed	a	multivariate	regression	approach	where	only	the	most
informative	loci	responsible	for	ephelides	were	included,	in	order	to	predict	human	ephelides	occurrence.	To	test	the	power	of	the	newly-generated	freckle	prediction	model	in	future	forensic	applications,	we	evaluated	the	model’s
prediction	performance	in	terms	of	accuracy,	sensitivity	and	specificity	by	means	of	a	cross-validation	approach	as	well	as	an	external	validation	using	an	independent	sample.
2	Materials	and	methods
2.1	Study	subjects	and	data	collection
2.1.1	Original	population
A	total	of	458	individuals	(266	non-freckled	controls	and	192	freckled	cases)	were	included	in	this	study.	Initially,	unrelated	participants	were	randomly	selected,	the	percentage	of	the	freckling	phenotype	being	21.86%	in	our	population.	These
participants	were	recruited	among	the	students	and	staff	of	the	Jaume	I	University	of	Castellon.	With	the	aim	of	performing	a	case-control	association	study,	additional	consecutive	freckled	volunteers	were	included	in	our	study	population.	All	individuals
were	Europeans	of	Spanish	origin.	Written	informed	consent	was	provided	by	all	participants,	and	the	study	was	approved	by	the	Ethics	Committee	of	the	Jaume	I	University	of	Castellon	(Castellon,	Spain).
Under	the	supervision	of	a	professional,	each	participant	completed	a	standardised	questionnaire	to	collect	information	on	sex,	age,	pigmentation	traits,	history	of	childhood	sunburns,	Fitzpatrick’s	skin	type	classification,	and	sun	exposure	habits.
Details	of	ephelides	occurrence	both	during	the	infancy	or	adolescence	periods	and	in	adulthood	were	collected	in	the	questionnaire	(an	illustration	is	shown	in	Fig.	S1	in	Supplementary	material	in	online	version	at	DOI:	10.1016/j.fsigen.2017.11.013).
2.1.2	Independent	validation	population
A	second	phase	of	the	study	was	composed	of	212	unrelated	individuals	(109	non-freckled	controls	and	103	freckled	cases)	of	Spanish	origin,	also	recruited	among	the	students	and	staff	of	the	Jaume	I	University	of	Castellon.	All	individuals	gave	a
written	informed	consent	and	completed	the	standardised	questionnaire	used	to	collect	phenotypic	information.
2.2	DNA	extraction
Genomic	DNA	was	obtained	from	buccal	swabs	that	were	stored	at	−20	°C	until	sample	processing.	DNA	was	isolated	using	QIAamp	DNA	Mini	Kit	(Qiagen,	Hilden,	Germany),	according	to	the	manufacturer’s	protocol.	After
DNA	extraction,	all	samples	were	diluted	to	a	concentration	of	5	ng/μl	in	order	to	prepare	them	for	 PCR	amplification.
2.3	SNP	selection	and	genotyping
Previous	 literature	 was	 used	 to	 select	 our	 candidate	 gene	 list.	 We	 opted	 for	 genes	 previously	 associated	 with	 sensitivity	 to	 sunlight	 and/or	 freckling	 [8,11,16–20].	 Eventually,	 eight	 SNPs	 located	 in	 seven
pigmentation-related	genes	were	selected	and	genotyped:	rs4911442	located	in	the	ASIP	gene	[8,16,20],	rs2153271	in	the	BNC2	gene	[16],	rs12896399	in	SLC24A4	[18],	rs16891982	in	SLC45A2	[19],	rs1393350	and	rs1042602	in	the	TYR
gene	[18],	rs12203592	in	IRF4	[18–20],	and	rs12821256	in	the	KITLG	gene	[18].	Other	candidate	SNPs	mentioned	in	the	cited	literature	were	excluded	due	to	SNP	redundancy	or	to	extremely	low	frequencies	in	the	Spanish	population.
SNP	codes,	locations,	ancestral	and	derived	alleles	and	their	frequencies	were	obtained	from	the	Ensembl	Variation	database	(http://www.ensembl.org/info/genome/variation/index.html).
Genotyping	 assays	were	 performed	by	 using	KASP	Genotyping	Chemistry	 (LGC,	Hoddesdon,	United	Kingdom).	 For	SLC45A2	 rs16891982,	 TaqMan	 technology	was	used	 (Applied	Biosystems,	Foster	City,	USA).	Genotyping
analyses	 were	 carried	 out	 in	 a	 StepOnePlusTM	 Real-Time	 PCR	 System,	 with	 varying	 PCR	 conditions	 depending	 on	 the	 requirements	 of	 each	 probe.	 The	 genotype	 of	 each	 sample	 was	 determined	 by	 measuring	 allele-specific
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fluorescence,	 using	 SDS	 v2.3	 software	 for	 allelic	 discrimination	 (Applied	Biosystems,	 Foster	City,	USA).	 For	 quality	 control,	we	 included	 a	 negative	 control	 and	 a	 trio	 of	 samples	with	 known	 genotype	 (major	 allele	 homozygous,
heterozygous	and	rare	allele	homozygous)	in	each	96-well	plate.
2.4	Sequencing	of	MC1R	coding	region
All	 DNA	 samples	 were	 analysed	 for	 the	 coding	 sequence	 of	 the	MC1R	 gene	 by	 direct	 automated	 DNA	 sequencing,	 as	 previously	 described	 [21].	 The	 primers	 used	 to	 amplify	 the	MC1R	 coding	 region	 were:	MC1R-F	 (5′-
CAGCACCATGAACTAAGCAGGACACCTG-3′)	and	MC1R-R	(5′-AAGGGTCCGCGCTTCAACACTTTCAGAG-3′).	Amplification	was	carried	out	by	using	Type-it™	Microsatellite	PCR	Kit	(Qiagen,	Hilden,	Germany),	following	the	manufacturer’s
instructions.	PCR	products	were	purified	with	EnzSAP	(EdgeBio,	Gaithersburg,	USA)	and	subsequently	sequenced	by	direct	gene	sequencing	with	the	Sanger	method.	A	sample	with	known	MC1R	genotype	per	96-well	plate	was	added
for	quality	control.	All	sequencing	results	were	analysed	using	SeqScape	v2.5	software	to	align	and	detect	all	nucleotide	changes.	All	detected	sequence	changes	were	confirmed	manually.
Non-synonymous	MC1R	mutations	were	then	defined	as	‘R’,	‘r’	or	‘p’	(pseudoallele)	alleles	according	to	their	impact	on	protein	function	(Table	1).	R	alleles	included	genetic	variants	that	have	been	associated	with	the	red	hair
colour	(RHC)	phenotype	[22,23],	and	have	been	shown	to	cause	a	significant	impairment	of	receptor	function	in	previous	functional	in	vitro	or	in	silico	analysis	[21,24–29].	Genetic	variants	that	have	not	been	associated	with	the	RHC
phenotype	[23,30,31],	and	have	been	shown	to	display	partial	loss	of	function	or	present	a	possibly	damaging	effect	based	on	prediction	analysis	[25,27,32,33],	were	defined	as	r	alleles.	Variants	in	which	receptor	function	is	similar	to	the
wild-type	form	were	catalogued	as	p	alleles.	Individuals	were	classified	based	on	the	number	of	R	and/or	r	alleles	carried.
Table	1	MC1R	variants	with	protein	sequence	alterations	identified	in	the	current	study.
alt-text:	Table	1
Variant Nucleotide	change Functional	analysis Prediction	analysis Polyphen	score Reference
R	alleles
D84E c.252C	>	A Yes – – Beaumont	et	al.	[23]
R142H c.425G	>	A Yes – – Beaumont	et	al.	[23]
R151C c.451C	>	T Yes – – Beaumont	et	al.	[22]
I155T c.464T	>	C Yes – – Beaumont	et	al.	[23]
R160W c.478C	>	T Yes – – Beaumont	et	al.	[22]
D294H c.880G	>	C Yes – – Beaumont	et	al.	 [22]
Q30X c.88C	>	T No No – Guan	et	al.	[24]
C35Y c.104G	>	A Yes – – Fargnoli	et	al.	[32]	and	Fernandez	et	al.	[29]
S41F c.122C	>	T Yes – – Pérez	Oliva	et	al.	[28]
S83P c.247T	>	C No Yes – Kanetsky	et	al.	[26]	and	Ibarrola-Villava	et	al.	 [36]
S83L c.248C	>	T Yes – – Ozola	et	al.	[27]
G89R c.265G	>	C Yes – – Ozola	et	al.	[27]
M128T c.383T	>	C Yes – – Pérez	Oliva	et	al.	[28]
L135R c.404T	>	G No No 1.000 NEW.	Never	reported/not	found	in	SNPs	databases
Y152X c.456C	>	A Yes – – Fargnoli	et	al.	[32]
Q233X c.697C	>	T No No – Martinez-Cadenas	et	al.	[35]
P256S c.766C	>	T No Yes – Kanetsky	et	al.	[26]
(2006)
(2013)
Hu	et	al.	(2014)
P268R c.803C	>	G No Yes – Ibarrola-Villava	et	al.	[25]
r	alleles
V60L c.178G	>	T Yes – – Beaumont	et	al.	[23]	and	Herraiz	et	al.	[30]
V92M c.274G	>	A Yes – – Beaumont	et	al.	[23]	and	Herraiz	et	al.	[30]
R163Q c.488G	>	A Yes – – Beaumont	et	al.	[23]	and	Nakayama	et	al.	[31]
L24M c.70C	>	A No No 0.863 NECTAR	(http://nectarmutation.org)
F45L c.133T	>	C No Yes – Ozola	et	al.	[27]	and	Ibarrola-Villava	et	al.	[25]
L46V c.136C	>	G No No 0.741 Ensembl	(www.ensembl.org)
R67Q c.200G	>	A No Yes – Fargnoli	et	al.	[32]
T95M c.284C	>	T Yes – – Ozola	et	al.	[27]
I120T c.359T	>	C No Yes – Fargnoli	et	al.	[32]
V122M c.364G	>	A Yes – – Jimenez-Cervantes	et	al.	[33]
V156A c.467T	>	C No No 0.784 Kanetsky	et	al.	[26]
V193L c.577G	>	T No No 0.567 Ensembl	(www.ensembl.org)
N279K c.837C	>	A No Yes – Fargnoli	et	al.	[32]	and	Ibarrola-Villava	et	al.	[25]
p	alleles
G32R c.94G	>	A No No 0.299 NEW.	Never	reported/not	found	in	SNPs	databases
S47T c.140G	>	C No No 0.003 Garcia-Borron	et	al.	[57]
A57V c.170C	>	T No No 0.001 Ensembl	(www.ensembl.org)
G89E c.265G	>	A No No 0.170 Ensembl	(www.ensembl.org)
M128V c.382A	>	G No No 0.019 NECTAR	(http://nectarmutation.org)
A167T c.499G	>	A No No 0.024 Ensembl	(www.ensembl.org)
V208I c.622G	>	A No No 0.002 Ensembl	(www.ensembl.org)
Only	variants	with	protein	sequence	alterations	are	shown.	Previous	in	vitro	or	in	silico	functional	analysis	were	used	to	classify	MC1R	variants	into	three	categories.	In	the	absence	of	previous	published	data,	impact
on	receptor	function	was	predicted	by	the	PolyPhen	programme.	Genetic	variants	with	PolyPhen	scores	lower	than	0.50	were	considered	as	p	alleles	(pseudoalleles	with	similar	function	compared	to	wild-type),	while
variants	with	scores	from	0.50	to	0.95	were	classified	as	r	alleles	(possibly	damaging).
2.5	Association	analysis
Association	analyses	were	performed	using	the	R	software	(http://www.R-project.org).	All	analyses	performed	were	two-sided,	and	a	significance	level	of	0.05	was	considered	for	rejection	of	the	null-hypothesis.	The	conservative
Bonferroni	correction	was	used	to	adjust	the	significance	level	for	multiple	testing	(P-value	<	4.54	×	10−3	=	0.05/11).	Unknown	and	missing	values	were	excluded	at	each	specific	analysis.
For	each	polymorphism	studied,	Fisher’s	exact	test	was	used	to	check	for	deviations	from	Hardy-Weinberg	equilibrium	(HWE)	among	controls.	Minor	allele	frequencies	(MAFs)	for	freckled	and	non-freckled	individuals	were
estimated	from	our	population.
Gan-Or	et	al.	(2016)
Associations	between	the	genotyped	polymorphisms	and	the	presence	of	ephelides	were	assessed	according	to	the	co-dominant	model	of	 inheritance	via	binary	 logistic	regression.	Genotype-related	odds	ratios	(ORs),	 their
corresponding	95%	confidence	intervals	(CIs)	and	associated	P-values	were	estimated.	The	proportion	of	the	total	variance	in	freckling	explained	by	each	genetic	variant	was	estimated	using	Nagelkerke	pseudo-R2	statistic	(R2).	This
statistic	parameter	was	used	to	rank	the	genetic	variants	included	in	the	study	based	on	their	contribution	to	the	freckling	phenotype.
2.6	Prediction	model
A	multivariate	logistic	regression	approach	was	applied	to	build	the	prediction	models.	The	DNA-based	freckle	prediction	model	was	developed	using	backward	elimination	of	genetic	variants	based	on	the	Akaike	information
criterion	(AIC),	being	the	optimal	model	the	one	with	the	smaller	AIC	value	–	best	balance	between	goodness-of-fit	and	parsimony.	For	each	iteration,	the	lowest	predictor	in	the	variable	set	is	excluded.	Then,	the	model	is	rebuilt,	used
to	predict	again	freckle	occurrence,	and	the	quality	of	the	newly	generated	model	is	re-tested.	This	model-building	process	is	repeated	until	all	remaining	polymorphisms	included	in	the	prediction	model	have	a	statistically	significant
contribution,	and	the	estimated	information	loss	is	minimised.
To	assess	 the	 influence	of	 sex	 in	 the	 freckling	phenotype,	 the	DNA-based	prediction	model	was	additionally	adjusted	by	 including	sex,	as	well	as	 the	 interaction	between	sex	and	each	genetic	variant	as	covariates	 in	 the
multivariate	logistic	regression.	As	above,	the	optimal	sex-adjusted	prediction	model	was	developed	based	on	the	AIC	variable	selection	criteria.
Finally,	statistical	interactions	between	genetic	variants	were	examined	using	the	MDR	software	(http://www.epistasis.org/).	The	multifactor	dimensionality	reduction	method	is	a	powerful	strategy	for	detecting	and	interpreting
statistical	locus–locus	epistasis	[34].	Dendrogram	interaction	graphs	provided	by	MDR	illustrate	the	presence,	strength,	and	nature	of	epistatic	effects.	Pairwise	genetic	interactions	were	tested	by	including	interactions	into	the	logistic
regression	model.
2.7	Model	evaluation
2.7.1	Internal	evaluation	phase	–	cross-validation
In	order	to	evaluate	the	predictive	ability	of	the	freckle	prediction	models,	we	applied	a	repeated	10-fold	cross-validation	approach.	Briefly,	individuals	were	randomly	divided	into	10	equal	data	subsets.	For	each	round	of	cross-validation,	nine	data
subsets	were	used	for	performing	the	analysis	(training	set)	while	the	remaining	subset	was	used	for	validating	the	analysis	(testing	set).	This	process	was	run	10	times,	using	a	different	subset	as	testing	set	each	time.	This	entire	procedure	was	repeated
200	times,	using	different	random	partitions	of	the	original	sample	to	protect	against	chance	divisions	of	the	dataset.	Data	partition	was	carried	out	using	the	‘caret	package’	for	R	software,	and	the	repeated	cross-validation	approach	was	performed	with
custom	programmes	written	in	R.
Receiver	operating	characteristic	 (ROC)	curve	analysis	was	adopted	to	evaluate	the	cross-validated	performance	of	 the	prediction	models.	The	Youden	Index	method	was	used	to	set	 the	optimal	cut-off	point	–	 the	point	on	the	curve	at	which
(sensitivity	+	specificity−1)	is	maximised.	For	each	prediction	model,	basic	prediction	accuracy	parameters	–	including	the	area	under	the	ROC	curve	(AUC),	sensitivity,	specificity	and	accuracy	–	were	calculated	from	the	confusion	table	reporting	the
number	of	true	positives	(TP),	true	negatives	(TN),	false	positives	(FP),	and	false	negatives	(FN).	The	final	values	reported	were	averaged	from	the	200	×	10	individual	cross-validation	curves	to	produce	a	single	estimation.	All	calculations	and	plots	were
performed	using	the	‘ROCR	package’	for	R	software.
2.7.2	External	evaluation	phase	–	independent	population
In	order	to	carry	out	the	external	evaluation,	only	the	genetic	variants	that	were	significantly	associated	with	freckles	in	the	first	phase	of	the	study	–	IRF4,	ASIP,	BNC2	and	MC1R	–	were	analysed	in	the	newly	collected	independent	samples.
This	 independent	dataset	was	used	to	assess	the	performance	of	the	newly-generated	freckle	prediction	model	regarding	the	correct	classification	of	 individuals	as	 freckled	or	non-freckled.	Subsequently,	a	comparison	between	predicted	and
observed	data	was	performed,	and	the	basic	accuracy	parameters	(AUC,	sensitivity,	specificity	and	accuracy)	were	calculated	from	the	confusion	table	by	using	the	‘pROC	package’	for	R	software.
3	Results
Our	original	sample	set	comprised	266	non-freckled	and	192	freckled	individuals	of	Spanish	ancestry	(Table	2).	The	study	cohort	included	260	females	(56.52%)	and	198	males	(43.04%).	Interestingly,	the	prevalence	of	the
freckling	phenotype	was	remarkably	higher	in	females	than	in	males	(68.75%	vs	31.25%,	P-value	=	9.00	×	10−9).	As	expected,	freckled	individuals	were	more	likely	to	have	skin	phototypes	I–II	and	childhood	sunburns	than	non-freckled
individuals,	although	no	significant	differences	between	them	were	found	regarding	sun	exposure	habits	(Table	2).
Table	2	Classification	of	the	Spanish	individuals	according	to	sex,	skin	phototype	and	sun	exposure	habits.
alt-text:	Table	2
Non-freckled	(N	=	266) Freckled	(N	=	192) P-valuea
N % N %
Sex
Female 128 48.12 132 68.75 9.00E-06
Male 138 51.88 60 31.25
Unknown 0 0.00 0 0.00
Sun	exposure
Never 22 8.27 17 8.85 0.438
Intermittent 134 50.38 106 55.21
Habitual 109 40.98 65 33.85
Unknown 1 0.38 9 4.69
Skin	Phototype
III/IV 203 76.32 69 35.94 9.20E-18
I/II 63 23.68 121 63.02
Unknown 0 0.00 2 1.04
Childhood	sunburns
No 126 47.37 37 19.27 3.52E-09
Yes 138 51.88 145 75.52
Unknown 2 0.75 10 5.21
N,	number	of	individuals;	%,	percentage	of	individuals	per	group	among	the	total.
a P-value	for	the	Fisher's	exact	test.	Significant	results	are	presented	in	bold.
For	each	polymorphism,	minor	allele	frequencies	in	freckled	and	non-freckled	individuals	from	our	population	are	detailed	in	Table	3.	Evidence	of	departure	from	Hardy-Weinberg	equilibrium	among	controls	was	observed	for
two	SNPs:	rs12896399	in	SLC24A4	gene	and	rs16891982	in	SLC45A2	–	as	seen	in	previous	studies	involving	these	human	pigmentation	genes	[35–37].	Out	of	458	individuals	studied,	277	(60.48%)	carried	at	least	one	non-synonymous
MC1R	variant,	including	135	(54.43%)	in	a	total	of	248	non-freckled	individuals,	and	142	(75.93%)	in	a	total	of	187	freckled	individuals.	All	genetic	variants	found	in	the	MC1R	gene	are	listed	and	classified	in	Table	1.	To	our	knowledge,
two	mutations	(G32R	and	L135R)	have	never	been	previously	described,	and	they	add	up	to	the	growing	list	of	rare	MC1R	natural	variants.	The	frequencies	of	R	and	r	alleles	in	both	freckled	and	non-freckled	individuals	are	detailed	in
Table	3.	Seventeen	samples	were	discarded	due	to	unsuccessful	MC1R	sequencing.
Table	3	Genotypic	association	with	freckles	in	the	Spanish	population.
alt-text:	Table	3
Gene SNP	 rs	No. Genotype Non -freckled	individuals Freckled	individuals P-valuea OR	(95%	CI) R2	(%)b Rankc# 	
N % MAF HWE	P-value N % MAF
ASIP rs4911442 AA 233 87.59 0.062 0.264 153 79.69 0.109 0.044 reference 1.01 4
AG 29 10.90 36 18.75 1.89	(1.11–3.21)
GG 2 0.75 3 1.56 2.28	(0.38–13.83)
ND 2 0.75 0 0.00
BNC2 rs2153271 TT 68 25.56 0.476 0.222 61 31.77 0.406 0.067 reference 0.87 5
CT 143 53.76 106 55.21 0.83	(0.54–1.27)
CC 55 20.68 25 13.02 0.51	(0.28–0.91)
ND 0 0.00 0 0.00
IRF4 rs12203592 CC 207 77.82 0.117 1.000 100 52.08 0.275 1.81E−05* reference 5.92 2
CT 56 21.05 77 40.10 2.49	(1.57–3.94)
TT 3 1.13 14 7.29 6.56	(1.68–25.54)
ND 0 0.00 1 0.52
KITLG rs12821256 TT 243 91.35 0.041 1.000 175 91.15 0.034 0.417 reference 0.11 9
CT 21 7.89 11 5.73 0.73	(0.34–1.56)
CC 0 0.00 0 0.00 –
ND 2 0.75 6 3.13
MC1R R	alleles 0/0 214 80.45 – – 110 57.29 – 7.05E−08* reference 6.91 1
0/1 38 14.29 64 33.33 3.26	(2.05–5.18)
1/1 2 0.75 13 6.77 11.61	(2.55–52.83)
ND 12 4.51 5 2.60
MC1R r	alleles 0/0 154 57.89 – – 92 47.92 – 0.039 reference 1.09 3
0/1 86 32.33 77 40.10 1.49	(1.01–2.24)
1/1 14 5.26 18 9.38 2.15	(1.02–4.53)
ND 12 4.51 5 2.60
SLC24A4 rs12896399 TT 92 34.59 0.439 0.033 58 30.21 0.479 0.521 reference 0.21 7
GT 113 42.48 85 44.27 1.20	(0.77–1.85)
GG 60 22.56 49 25.52 1.33	(0.80–2.19)
ND 1 0.38 0 0.00
SLC45A2 rs16891982 GG 209 78.57 0.133 0.002 154 80.21 0.130 0.690 reference 0.12 8
CG 43 16.17 26 13.54 0.82	(0.48–1.39)
CC 14 5.26 12 6.25 1.16	(0.52–2.59)
ND 0 0.00 0 0.00
TYR rs1393350 GG 75 28.30 0.239 1.000 58 30.21 0.259 0.777 reference 0.08 10
AG 134 50.57 102 53.13 1.10	(0.75–1.63)
AA 56 21.13 32 16.67 1.27	(0.58–2.78)
ND 1 0.38 0 0.00
TYR rs1042602 CC 154 57.89 0.464 0.902 105 54.97 0.432 0.485 reference 0.23 6
AC 97 36.47 73 38.22 0.98	(0.64–1.51)
AA 15 5.64 13 6.81 0.74	(0.42–1.28)
ND 0 0.00 1 0.52
SNP,	single	nucleotide	polymorphism;	N,	number	of	individuals;	%,	percentage	of	individuals	per	group	among	the	total;	OR,	odds	ratio	per	minor	allele;	CI,	confidence	interval;	R2,	Nagelkerke	pseudo-R2	statistic.
* Indicates	significant	results	at	Bonferroni	threshold	of	4.50E-03.
a P-value	for	the	binary	logistic	regression	association	analysis	according	to	the	co-dominant	model	of	inheritance.	Bold	indicates	statistically	significant	results.
b The	proportion	of	total	variance	in	freckling	phenotype	explained	by	the	genetic	variants	was	estimated	using	R2.
c The	genetic	variants	were	ranked	according	to	their	importance	in	freckling	phenotype.
Univariate	association	analyses	were	performed	to	assess	the	independent	effects	of	each	genetic	variant	on	freckling	occurrence	in	childhood	(Table	3).	R	variants	of	the	MC1R	gene	were	the	alleles	most	strongly	associated
with	freckling	(P-value	=	7.05	×	10−8),	explaining	6.91%	of	the	variance.	The	rs12203592	polymorphism	in	the	IRF4	gene	presented	the	second	strongest	association	with	the	presence	of	ephelides	(P-value	=	1.81	×	10−5),	explaining
5.92%	of	the	variance.	Weaker	significant	associations	were	also	observed	for	r	variants	(P-value	=	0.039)	and	rs4911442	in	ASIP	(P-value	=	0.044),	explaining	around	1%	of	the	variance	(R2	=	1.09%	and	R2	=	1.01%,	respectively).	No
associations	were	found	for	the	remaining	six	polymorphisms,	although	rs2153271	in	BNC2	showed	a	marginal	significant	association	with	freckling	(P-value	=	0.067).
A	prediction	model	was	then	constructed	based	on	multinomial	logistic	regression.	To	design	the	optimal	model,	we	performed	a	step-wise	analysis	by	iteratively	excluding	the	lowest	predictor	from	the	multinomial	logistic
regression	model.	The	genetic	variants	were	ranked	according	to	their	 impact	on	freckling.	The	DNA-based	prediction	model	 included	four	loci	(MC1R,	IRF4,	ASIP	and	BNC2),	which	together	explained	about	30%	of	the	freckling
phenotype	variance	in	our	population	(Table	4).	A	repeated	10-fold	cross-validation	approach	was	used	to	perform	an	internal	validation	of	the	DNA-based	prediction	model	by	ROC	analysis,	which	tests	the	power	of	the	prediction
model	[38].	The	prediction	accuracy	of	the	tested	DNA-based	prediction	model	was	74.13%	in	the	population,	with	an	AUC	of	0.771,	a	specificity	of	82.00%,	and	a	sensitivity	of	63.51%	(Fig.	1A).
Table	4	Multivariate	logistic	regression	testing	freckle 	association	with	genetic	variants	and	sex.
alt-text:	Table	4
DNA-based	prediction	model Sex-adjusted	prediction	model
Gene SNP	rs 	No. Variable OR	(95%	CI) P-valuea OR	(95%	CI) P-valuea
MC1R R	alleles 1/0 4.18	(2.49–7.02) 6.66E-08 4.21	(2.48–7.15) 1.02E-07
1/1 21.51	(4.50–102.79) 1.20E-04 21.94	(2.48–105.16) 1.12E-04
IRF4 rs12203592 CT 3.28	(2.05–5.26) 7.75E-07 3.26	(2.02–5.27) 1.43E-06
TT 15.51	(3.26–73.76) 5.65E-04 14.63	(3.06–70.10) 7.81E-04
MC1R r	alleles 1/0 2.08	(1.30–3.32) 2.20E-03 2.05	(1.28–3.30) 2.92E-03
1/1 3.45	(1.51–7.87) 3.20E-03 3.39	(1.43–7.99) 5.35E-03
s
#
ASIP rs4911442 AG 2.26	(1.22–4.17) 9.27E-03 2.38	(1.28–4.45) 6.49E-03
GG 3.65	(0.35–38.40) 0.281 5.15	(0.47–56.62) 0.181
BNC2 rs2153271 CT 0.91	(0.55–1.49) 0.706 0.98	(0.59–1.63) 0.937
CC 0.45	(0.23–0.90) 0.023 0.48	(0.24–0.97) 0.040
Male	sex – – 0.49	(0.32–0.79) 2.70E-03
SNP,	single	nucleotide	polymorphism;	OR,	odds	ratio	per	minor	allele;	CI,	confidence	interval.
Optimal	model	selection	procedure	was	based	on	the	Akaike	information	criterion	(AIC).
a P-value	for	the	multivariate	logistic	regression	association	analysis.	Bold	indicates	significant	results	at	Bonferroni	threshold	of	4.50E-03.
The	inclusion	of	sex	on	the	freckle	prediction	model	appeared	to	increase	the	prediction	accuracy	by	2.19%,	to	a	total	of	76.32%	(Fig.	1B).	Slight	increases	in	AUC	(0.781),	specificity	(83.80%)	and	sensitivity	(66.21%)	values
were	 observed	when	 sex	was	 taken	 into	 account.	 The	 results	 of	 the	multivariate	 association	 analysis	 confirmed	 sex	 as	 an	 important	 variable	 in	 the	 estimation	 of	 the	 freckling	 phenotype	 (P-value	=	 2.70	×	 10−3).	 No	 significant
Fig.	1	Average	receiver	operating	characteristic	curves	for	repeated	cross-validated	model	assessment	of	the	A)	DNA-based;	and	B)	sex-adjusted	freckle	prediction	models.	Prediction	models	were	developed	with	a	Spanish	population	set	using	multivariate
logistic	regression.	Repeated	10-fold	cross-validation	was	used	to	assess	the	performance	of	the	prediction	models.	Faint	grey	lines	represent	ROC	curves	for	each	of	the	individual	cross-validation	curves.	Solid	black	line	represents	the	overall	average	of	all
ROC	curves.	Mean	values	of	the	basic	accuracy	parameters	are	displayed.	Optimal	cut-off	was	selected	for	maximising	Youden	Index.	AUC,	area	under	the	curve.
alt-text:	Fig.	1
interaction	between	sex	and	other	genetic	predictors	was	found.
An	external	validation	of	the	newly-generated	prediction	model,	assessing	the	model	generalisability	[39],	was	also	performed	by	collecting	an	independent	cohort	of	212	individuals	–	though	only	193	individuals	successfully
genotyped	for	all	loci	were	included	in	the	external	validation.	The	prediction	accuracy	of	the	freckle	prediction	model	was	74.61%	in	the	independent	cohort,	with	an	AUC	of	0.809,	a	specificity	of	89.12%,	and	a	sensitivity	of	59.79%.	A
total	of	49	individuals	were	incorrectly	predicted	(misclassification	rate	of	25.39%)	(Table	5).
Table	5	Accuracy	of	the	sex-adjusted	freckle	prediction	model	obtained	from	an	independent	cohort	of	Spanish	individuals.
alt-text:	Table	5
Prediction	model Phenotype Predicted	phenotype Totalb Prediction	accuracy	parameters
Freckled Non-freckled AUC Sensitivity	(%) Specificity	(%) Accuracy	(%)
Sex-based	prediction	modela Freckled 55 37 92 0.809 59.79 89.12 74.61
Non-freckled 12 89 101
Total 67 126 193
Fails	(%) 12	(17.91) 37	(29.36) 49	(25.39)
aOptimal	cut-off	maximising	Youden	Index	(0.6138)	was	used	to	classify	individuals.
bGenetic	analyses	of	four	loci	were	successfully	performed	in	193	out	of	212	individuals	(missing	rate	of	8.96%).
We	also	evaluated	the	prediction	capacity	of	the	sex-adjusted	prediction	model	to	determine	the	freckling	phenotype	in	adulthood.	Taking	into	account	that	freckles	often	disappear	after	adolescence	or	during	young	adulthood,
the	success	rate	of	the	prediction	model	was	relatively	good	in	our	population	(69.63%),	with	a	high	true	negative	rate	(specificity	of	80.70%)	but	a	low	true	positive	rate	(sensitivity	of	58.91%)	(Fig.	2).	Out	of	all	six	freckle	predictors
included	in	the	model,	only	the	r	variants	in	MC1R	did	not	show	a	significant	contribution	to	freckling	in	adulthood	(P-value	>	0.05).
Fig.	2	Area	under	the	receiver	operating	characteristic	curves	for	the	sex-adjusted	freckle	prediction	model	in	adulthood.	Individuals	from	both	the	first	(model	building	and	internal	validation)	and	the	second	phase	(external	validation)	of	the	study	were
pooled	to	perform	this	analysis.	Using	Youden	Index,	optimal	cut-off	was	selected	for	maximising	the	sensitivity	and	specificity	of	the	prediction	model	to	classify	individuals.	AUC,	area	under	the	curve.
alt-text:	Fig.	2
MDR	analysis	for	locus–locus	interaction	detection	indicated	that	the	best	freckle	prediction	model	was	composed	by	four	genetic	variables	and	sex	(BNC2	rs2153271	was	not	included).	The	locus–locus	interaction	analysis
showed	a	redundant	interaction	between	R	variants	in	the	MC1R	gene	and	rs12203592	in	the	IRF4	gene,	denoted	by	the	blue	lines	connecting	these	two	genetic	determinants	in	the	dendrogram	(Fig.	S2	in	Supplementary	material	in
online	version	at	DOI:	10.1016/j.fsigen.2017.11.013).	However,	 the	 inclusion	of	 this	genetic	 interaction	 in	our	 freckle	prediction	model	did	not	 significantly	modify	 the	prediction	capacity	using	a	 repeated	10-fold	 cross-validation
approach	(AUC	=	0.768,	specificity	=	83.20%,	sensitivity	=	61.27%,	and	accuracy	=	75.45%).
4	Discussion
In	the	current	study,	eight	freckle	and	sunlight	sensitivity-related	genes	were	genotyped	in	458	individuals	from	Spain,	with	the	intention	of	analysing	their	putative	implication	in	the	appearance	of	ephelides,	and	its	potential
for	future	forensic	applications.	However,	only	the	438	individuals	successfully	genotyped	for	all	loci	were	included	in	the	development	and	cross-validation	of	the	prediction	model.	Furthermore,	an	external	evaluation	of	the	freckle
prediction	model	was	performed	on	an	extra	212	sample	independent	dataset	by	genotyping	the	genetic	variants	associated	with	freckling	in	the	original	population.
In	the	last	few	years,	the	genetic	basis	of	ephelides	has	been	adequately	studied	in	populations	of	North	European	origin	[11,16–18].	However,	little	is	known	about	the	genetic	determinants	of	this	pigmentation	characteristic
in	 southern	European	populations.	Our	 results	 showed	 an	 association	 between	 ephelides	 and	 genetic	 variants	 in	 the	 IRF4,	MC1R	 and	ASIP	 genes	 in	 a	Mediterranean	 population,	 confirming	 previous	 studies	 performed	 in	North
European	populations	[11,17,18].	R	variants	of	the	MC1R	gene	ha ve	been	previously	acknowledged	as	the	most	relevant	locus	associated	 with	both	freckling	and	sun	sensitivity.	The	abnormal	function	of	this	receptor	leads	to	a
higher	phaeomelanin	to	eumelanin	ratio,	commonly	resulting	in	the	well-known	freckle-generating	RHC	phenotype.	IRF4	has	also	been	associated	 with	freckling	in	several	studies	[8,18].	This	interferon	regulatory	factor	cooperates
with	MITF	to	activate	the	expression	of	tyrosinase	in	melanocytes,	a	function	which	seems	to	be	impaired	in	carriers	of	the	rs12203592*T	derived	allele	[40].	The	other	main	freckle-associated	loc us	in	this	study,	ASIP,	antagonises	the
activation	of	MC1R,	leading	to	a	down-regulation	of	eumelanogenesis	and	an	up-regulation	of	phae omelanogenesis.	Variants	in	this	gene,	also	previously	linked	to	the	RHC	phenotype,	may	therefore	have	effects	similar	to	variants	of
the	MC1R	gene	[16,17].
The	impact	of	BNC2	rs2153271	on	freckling	was	detected	only	after	applying	a	multivariate	association	approach.	The	identification	of	the	association	between	freckling	and	rs2153271,	located	in	an	intron	of	the	BNC2	gene,
was	recently	discovered	in	a	GWAS	study	performed	in	a	population	of	North	European	ancestry	[16],	and	was	additionally	correlated	with	acquired	facial	pigmented	spots	during	aging	[19].
Although	rs1042602	and	rs1393350,	in	the	TYR	gene,	have	been	previously	associated	with	freckling	in	two	European	populations	of	Icelandic	and	Dutch	origin	[18],	a	lack	of	association	between	these	two	SNPs	and	ephelides
occurrence	was	observed	in	our	Spanish	population.	Accordingly,	no	association	with	freckling	was	previously	observed	for	a	TYR	melanoma-associated	genetic	variant	(rs1126809)	 in	a	sample	set	comprising	three	Mediterranean
populations	from	France,	Spain	and	Italy	[36].	However,	that	melanoma	case-control	study	identified	a	moderate	association	between	rs16891982	in	SLC45A2	and	the	absence	of	ephelides	[36].	The	inheritance	of	a	set	of	genetic
variants	in	SLC45A2	was	also	associated	with	freckling	in	a	population	from	Brazil	[41].	However,	we	are	not	able	to	verify	this	association	in	the	current	study,	perhaps	due	to	the	limited	number	of	individuals	included	in	the	sample
set.
This	association	study	allows	us	to	develop	a	freckle	prediction	model	based	on	five	genetic	predictors:	R	variants	in	MC1R,	IRF4	rs12203592,	r	variants	in	MC1R,	ASIP	rs4911442	and	BNC2	rs2153271	(listed	in	order,	from
greater	to	lower	genetic	contribution).	Predicting	externally	visible	human	traits	from	genotypes	represents	a	potential	valuable	tool	in	forensic	investigations	[1].	However,	DNA-based	phenotyping	needs	a	very	demanding	approach
since	externally	visible	characteristics	are	typically	 influenced	by	several	genetic	as	well	as	environmental	factors	[42].	To	date,	DNA-based	human	eye	colour	prediction	is	the	most	accurate,	advanced	and	applied	test	 in	forensic
applications	[3–5,43].	The	IrisPlex	system,	a	robust	prediction	model	based	on	six	eye	colour	SNP	predictors,	has	been	validated	in	numerous	studies	for	forensic	eye	colour	prediction	[4,5,43].	Recently,	a	multiplex	genotyping	assay,
called	HIrisPlex,	has	been	developed	 for	simultaneous	hair	and	eye	colour	prediction	 [6],	being	suitable	and	sufficiently	sensitive	 for	 forensic	use	approval	 [44].	Currently,	 forensic	genome-wide	association	studies	are	 focused	on
increasing	the	genetic	determinants	of	different	phenotypes	such	as	body	height,	hair	shape,	baldness,	and	facial	variation,	in	order	to	reach	more	detailed	predictions	of	an	unknown	person’s	appearance	from	the	analysis	of	his/her
DNA	[16,45–48].
As	a	whole,	the	DNA-based	freckle	prediction	model	presents	with	high	specificity	(82.00%),	but	low	sensitivity	(63.51%).	The	low	sensitivity	levels	achieved	could	be	due	to	the	fact	that	one	third	of	the	individuals	carrying	R
variants	did	not	display	freckles,	suggesting	that	other	genetic	determinants	are	also	important	in	the	appearance	of	freckles.	Hopefully,	future	studies	with	increased	sample	sizes	may	add	to	the	genetic	factors	influencing	freckle
occurrence,	so	that	the	model’s	prediction	potential	may	be	significantly	improved.
Interestingly,	we	 found	a	much	higher	prevalence	of	ephelides	 in	 females	 than	 in	males.	Previous	studies	have	also	stated	discrepancies	 in	human	pigmentation	and	sunlight	sensitivity	 traits	between	sexes	 [19,35,49–52].
Notably,	 higher	 freckle	 prevalence	 in	 females	was	 previously	 observed	 in	 a	GWAS	 study	 performed	 in	 an	 northern	 European	 population	 [18].	 Additionally,	 Jacobs	 and	 cols.	 (2015)	 showed	 that	 females	 presented	 a	much	 higher
occurrence	of	facial	sun	spots	than	males,	being	the	total	variance	explained	by	sex	higher	than	any	of	the	genetic	variants	studied	[19].
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The	inclusion	of	sex	in	the	IrisPlex	model	has	been	proposed	to	improve	prediction	accuracy	mainly	for	intermediate	eye	colours	[35,50,53,54].	Adding	sex	as	a	covariate	in	our	DNA-based	freckle	prediction	model	slightly
increased	the	prediction	performance	for	ephelides	prevalence.	In	particular,	it	presented	with	both	higher	specificity	(83.80%)	and	sensitivity	(66.21%)	if	compared	to	the	prediction	model	based	on	the	five	freckle	genetic	predictors
alone.	Overall,	this	sex-adjusted	freckle	prediction	model	could	explain	a	high	proportion	of	the	freckling	phenotypic	variance	(R2	=	32.92%),	which	is	quite	large	compared	to	other	human	complex	traits	[55].
The	main	purpose	of	a	prediction	model	is	to	provide	correct	classification	for	new	individuals,	being	therefore	external	validation	a	crucial	phase	of	the	model	development	process.	Assessing	both	reproducibility	(internal
validation)	 and	 generalisability	 (external	 validation)	 of	 the	 developed	prediction	model	 are	 necessary	 in	 order	 to	 avoid	 overfitted	models	 [56].	However,	 application	 of	 a	 prediction	model	 should	 only	 be	 considered	 after	 proving
adequate	accuracies	in	an	independent	dataset.	For	this	reason,	the	discrimination	ability	of	the	newly-generated	prediction	model	was	assessed	by	comparing	the	observed	and	predicted	outcomes	in	a	new	dataset.	As	usually	noted	in
most	external	validations,	a	slight	decrease	of	the	overall	prediction	accuracy	was	observed	(from	76.32%	to	74.61%).
In	 terms	 of	 prediction	 power,	 our	 freckle	 prediction	model	 provided	 a	 similar	 accuracy	 than	 the	 one	 obtained	 for	 green/hazel	 eye	 colour	 prediction	 using	 IrisPlex	 (AUC	=	 0.809	 and	AUC	=	 0.76,	 respectively),	 although
significantly	lower	than	the	accuracy	level	achieved	for	brown	(AUC	=	0.93)	and	blue	eye	colour	prediction	(AUC	=	0.91)	[5].	HIrisPlex	also	presented	equivalent	prediction	power	for	hair	colour	prediction,	with	an	average	accuracy	of
73%	[44],	compared	to	74.61%	of	our	freckle	prediction	model.	Notice	that	our	results	have	been	reached	after	a	validation	approach	with	a	relatively	small	independent	sample,	while	both	IrisPlex	and	HIrisPlex	prediction	models	have
been	validated	in	independent	large	population	samples.
After	our	preliminary	validation,	the	freckle	prediction	model	developed	in	this	study	has	shown	to	display	limited	success,	but	it	also	appears	promising	for	future	applications	in	forensics.	However,	further	research	is	needed
to	increase	the	correct	prediction	rate	(sensitivity)	of	the	model,	since	the	percentage	of	freckled	individuals	predicted	as	non-freckled	is	considerably	high	(false	negative	rate	of	40.21%).
For	practical	considerations,	knowing	that	ephelides	tend	to	disappear	during	aging	due	to	undetermined	reasons,	we	tested	the	accuracy	of	our	prediction	model	to	determinate	the	presence	of	ephelides	in	adulthood.	The
model	presented	an	AUC	of	0.756,	a	slightly	lower	value	compared	to	the	AUC	value	obtained	for	freckle	prediction	in	childhood	(0.781	for	internal	cross-validation	and	0.809	for	external	validation).	No	significant	contribution	to
freckling	prediction	 in	adulthood	was	noted	 for	 r	variants,	 suggesting	 that	other	unknown	predictors	could	have	an	 independent	additional	 impact	on	 the	 freckling	phenotype	 in	adulthood.	 Interestingly,	after	adjustment	by	 IRF4
rs12203592	(the	most	associated	genetic	predictor	for	freckling	in	adulthood),	the	minor	allele	of	SLC45A2	rs16891982	was	weakly	associated	with	the	absence	of	freckles	in	adulthood	(OR	=	0.64	(0.43–0.94),	P-value	=	0.023).	As
revealed	by	the	MDR	analysis,	the	effect	of	this	SLC45A2	variant	may	not	be	strongly	influenced	by	a	locus–locus	interaction,	since	there	is	no	interaction	between	SLC45A2	and	the	rest	of	the	freckle	loci	(Fig.	S2B	in	Supplementary
material	in	online	version	at	DOI:	10.1016/j.fsigen.2017.11.013).
Since	the	sample	set	used	to	build	and	evaluate	this	freckle	prediction	model	was	relatively	small,	the	ability	to	accurately	predict	the	presence	of	ephelides	may	be	further	improved	by	using	larger	studies.	It	is	likely	that
phenotype	prediction	accuracy	may	be	substantially	improved	by	including	undiscovered	genetic	variants	at	novel	loci	or	by	taking	into	account	possible	gene	interactions	affecting	the	freckling	phenotype.	Also,	DNA	samples	from
different	populations	of	European	origin	should	be	included	in	further	studies	in	order	to	validate	this	DNA	predictive	test	for	future	forensic	applications.
It	 is	also	 important	 to	note	 that	predicting	complex	phenotypic	 traits	 from	DNA	studies	remains	a	difficult	 task	even	 if	all	genetic	 loci	 involved	–	and	the	 interactions	among	them	–	are	 taken	 into	account,	 since	different
environmental	factors	may	always	have	a	considerable	effect	(for	example,	the	effect	of	UV	exposure	on	freckle	occurrence).
5	Conclusions
The	main	genetic	variants	 involved	 in	 freckle	appearance	 in	 the	Spanish	population	are	 located	 in	 the	MC1R	and	IRF4	genes,	with	minor	contributions	 from	ASIP,	BNC2	and	perhaps	other	as	 yet	unknown	 freckle	genes.
However,	the	influence	on	freckling	of	different	MC1R	variants	(R	or	r)	is	substantially	different.	As	a	result,	the	DNA-based	model	for	freckle	prediction	developed	in	this	work	considers	five	genetic	determinants:	R	variants	of	the
MC1R	gene,	IRF4	rs12203592,	r	variants	of	the	MC1R	gene,	ASIP	rs4911442	and	BNC2	rs2153271	–	in	order	of	greatest	to	lowest	contribution	–	reaching	a	cross-validated	prediction	accuracy	of	up	to	74.13%,	a	more	than	respectable
percentage.	When	sex	is	added	to	the	model,	the	cross-validated	prediction	accuracy	reached	is	even	higher,	growing	up	to	76.32%.
Furthermore,	the	newly-generated	freckle	model	was	tested	in	an	independent	cohort	reaching	an	acceptable	specificity	level	of	89.12%.	However,	the	sensitivity	of	the	model	is	certainly	improvable,	attaining	a	percentage	of
around	60%.
For	a	more	detailed	pigmentation	phenotype	prediction,	future	research	may	focus	on	designing	multiplex	genetic	analysis	for	simultaneously	predicting	different	externally	visible	traits.	Perhaps	the	inclusion	of	two	more	SNPs
in	the	HIrisPlex	system,	BNC2	rs2153271	and	ASIP	rs4911442,	could	increase	the	forensic	potential	of	this	DNA-based	prediction	test	to	include	freckle	occurrence	(as	well	as	the	current	eye	and	hair	colour	prediction).
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E-Extra
For	practical	considerations,	knowing	that	ephelides	tend	to	disappear	during	aging	due	to	undetermined	reasons,	we	tested	the	accuracy	of	our	prediction	model	to	determin e	the	presence	of	ephelides	in
adulthood.	The	model	presented	an	AUC	of	0.756,	a	slightly	lower	value	compared	to	the	AUC	value	obtained	for	freckle	prediction	in	childhood	(0.781	for	internal	cross-validation	and	0.809	for	external	validation).
No	 significant	 contribution	 to	 freckling	 prediction	 in	 adulthood	was	 noted	 for	 r	 variants,	 suggesting	 that	 other	 unknown	 predictors	 could	 have	 an	 independent	 additional	 impact	 on	 the	 freckling	 phenotype	 in
adulthood.	Interestingly,	after	adjustment	by	IRF4	rs12203592	(the	most	associated	genetic	predictor	for	freckling	in	adulthood),	the	minor	allele	of	SLC45A2	rs16891982	was	weakly	associated	with	the	absence	of
freckles	 in	adulthood	 (OR	=	0.64	(0.43–0.94),	P-value	=	0.023).	As	 revealed	by	 the	MDR	analysis,	 the	effect	of	 this	SLC45A2	 variant	may	not	be	 strongly	 influenced	by	a	 locus–locus	 interaction,	 since	 there	 is	 no
interaction	between	SLC45A2	and	the	rest	of	the	freckle	loci	(Fig.	S2B).
E-component
Under	the	supervision	of	a	professional,	each	participant	completed	a	standardised	questionnaire	to	collect	information	on	sex,	age,	pigmentation	traits,	history	of	childhood	sunburns,	Fitzpatrick’s	skin	type
classification,	and	sun	exposure	habits.	Details	of	ephelides	occurrence	both	during	the	infancy	or	adolescence	periods	and	in	adulthood	were	collected	in	the	questionnaire	(an	illustration	is	shown	in	Fig.	S1).
MDR	analysis	 for	 locus–locus	 interaction	detection	 indicated	 that	 the	 best	 freckle	 prediction	model	was	 composed	by	 four	 genetic	 variables	 and	 sex	 (BNC2	 rs2153271	was	 not	 included).	 The	 locus–locus
interaction	analysis	showed	a	redundant	interaction	between	R	variants	in	the	MC1R	gene	and	rs12203592	in	the	IRF4	gene,	denoted	by	the	blue	lines	connecting	these	two	genetic	determinants	in	the	dendrogram
(Fig.	 S2).	However,	 the	 inclusion	 of	 this	 genetic	 interaction	 in	 our	 freckle	 prediction	model	 did	 not	 significantly	modify	 the	 prediction	 capacity	 using	 a	 repeated	10-fold	 cross-validation	 approach	 (AUC	=	0.768,
specificity	=	83.20%,	sensitivity	=	61.27%,	and	accuracy	=	75.45%).
at
Multimedia	Component	1
Fig.	S1	Examples	of	heavily	freckled,	lightly	freckled	and	non-freckled	individuals	of	Mediterranean	origin.
Multimedia	Component	2
Fig.	S2	Analysis	using	MDR	software	of	locus–locus	interactions	influencing	the	freckling	phenotype	in	A)	childhood	and	B)	adulthood.	Blue	lines	shown	in	entropic	dendrograms	represent 	redundant	interactions.s
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• Prediction	of	human	appearance	from	DNA	is	a	useful	tool	to	identify	unknown	persons.
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• Genetic	variants	in	MC1R,	IRF4,	ASIP	and	BNC2	contribute	to	freckling	in	Spain.
• A	preliminary	DNA-based	prediction	model	for	the	presence	of	ephelides	is	developed.
• Accuracy	of	the	newly-generated	freckle	prediction	model	is	reasonably	high.
• Further	research	is	needed	before	practical	use	in	forensics	of	the	newly-generated	freckle	model.
